SAN DIEGO, Oct. 10 /PRNewswire/ -- PacificGMP, a contract manufacturing organization specializing in the development and manufacturing of biologics through single-use bioprocessing components, announced today that it has signed an agreement with BD Biosciences, a segment of BD (Becton, Dickinson and Company), whereby PacificGMP will generate and provide storage for Master and Working Cell Banks and perform antibody manufacturing for BD Biosciences. The Master Cell Bank and antibody manufacturing will be conducted in compliance with current good manufacturing practices (cGMP) standards. Master and Working Cell Banks are a well-documented two-level storage system of mammalian cells. Cells from these banks may be used in production of biopharmaceuticals such as monoclonal antibodies, viral vectors or recombinant DNA products.
"We are pleased that BD Biosciences has chosen PacificGMP to perform mammalian cell banking and storage and antibody production under cGMP standards," said Leigh N. Pierce, president of PacificGMP. "PacificGMP is committed to the successful completion of this cell banking and antibody manufacturing project and to establishing a long-term development partnership with BD Biosciences."
PacificGMP is a contract manufacturing organization (CMO) and leader in the industry in single-use technology for development and manufacturing of biologics. Single-use technology eliminates the risk of cross-contamination, has fewer system requirements and significantly reduces the time required to initiate production. Benefits to clients include rapid project turnaround and the most cost effective solution in the industry. PacificGMP partners with drug developers by providing a range of cGMP and non-GMP services from early stages of process design, development and scale-up, to preclinical and clinical manufacturing. More information can be found by visiting the Company's web site at http://www.pacificGMP.com.
CONTACT: Gary Pierce, General Counsel and Chief Business Officer of
Web site: http://www.pacificgmp.com/